Advertisement
| nccn nsclc guidelines 2023: Central Nervous System Cancers Oncology Nursing Society, 2011 Considered one of the most devastating and frightening of all cancers, cancers of the central nervous system (CNS) attack the complex organs that control not only the CNS but also the peripheral nervous system and many of the voluntary and involuntary body systems, with 20% to 40% of CNS cancers metastasizing to the brain. Site-Specific Cancer Series: Central Nervous System Cancers, a new volume in the Series edited by Deborah Hutchinson Allen and Laurie L. Rice, details the cancers of the brain and spinal cord. Chapters examine issues such as anatomy and physiology of the brain and spine, patient assessment, pathology, histology, and molecular markers of primary brain tumors, and adult and pediatric cancers of the brain and spinal cord. Other issues include treatment modalities (surgical treatments, chemotherapy, and radiotherapy), as well as pediatric therapeutic modalities, symptom management and psychological issues, and the current state of evidence-based practice. You can use this new volume as a guide to treating your patients and to providing sensitive and realistic care that optimizes the quality of life and permits a sense of hopefulness to prevail when many patients with type of cancer feel only pain and fear. |
| nccn nsclc guidelines 2023: Stereotactic Body Radiation Therapy Simon S. Lo, Bin S. Teh, Jiade J. Lu, Tracey E. Schefter, 2012-08-28 Stereotactic body radiation therapy (SBRT) has emerged as an important innovative treatment for various primary and metastatic cancers. This book provides a comprehensive and up-to-date account of the physical/technological, biological, and clinical aspects of SBRT. It will serve as a detailed resource for this rapidly developing treatment modality. The organ sites covered include lung, liver, spine, pancreas, prostate, adrenal, head and neck, and female reproductive tract. Retrospective studies and prospective clinical trials on SBRT for various organ sites from around the world are examined, and toxicities and normal tissue constraints are discussed. This book features unique insights from world-renowned experts in SBRT from North America, Asia, and Europe. It will be necessary reading for radiation oncologists, radiation oncology residents and fellows, medical physicists, medical physics residents, medical oncologists, surgical oncologists, and cancer scientists. |
| nccn nsclc guidelines 2023: NCCN Guidelines for Patients® Non-Small Cell Lung Cancer Early and Locally Advanced National Comprehensive Cancer Network® (NCCN®), 2022-08-04 [OFFICIAL CURRENT VERSION] From the National Comprehensive Cancer Network (NCCN) comes this essential guide to Efectos secundarios de la inmunoterapia Inhibidores del punto de control inmunitario. Based on clinical treatment guidelines used by doctors and oncology professionals around the world, these NCCN Guidelines for Patients help patients and caregivers talk with their doctors and make treatment decisions. Topics include:Efectos secundarios de la inmunoterapia: aspectos básicos, Piel, Fatiga, Intestino e hígado, Hormonas, Pulmones, Músculos y articulaciones, Efectos secundarios menos comunes, Recursos, Palabras que debe saber, Colaboradores de NCCN, Centros oncológicos de NCCN, Índice. |
| nccn nsclc guidelines 2023: Imaging in Clinical Oncology Athanasios D. Gouliamos, John Andreou, Paris Kosmidis, 2013-11-26 This encompassing book is designed to contribute to a teamwork approach by promoting understanding between radiologists and clinical oncologists. All of the currently available imaging modalities of relevance in clinical oncology are covered, and the presentation of a broad spectrum of oncologic diseases (of most organ systems) on these modalities is discussed and illustrated. The role of multiparametric and multimodality imaging approaches providing both morphologic and functional information is considered in detail, and careful attention is paid to the latest developments in higher field (3T) MR imaging and advanced MR techniques such as diffusion-weighted imaging, diffusion tensor imaging, perfusion-weighted imaging and spectroscopy. The major challenge of incorporating progress in quantitative imaging technology into radiotherapy treatment planning, guidance, and monitoring is also addressed. This book will assist in refining the treatment approach in various oncologic diseases and organ systems based on specific imaging features. It will be of value to radiologists, oncologists, and other medical professionals involved in the diagnosis and treatment of oncology patients. |
| nccn nsclc guidelines 2023: Hypercalcemia of Malignancy Friedhelm Raue, 2012-12-06 Hypercalcemia is the most common life-threatening metabolic disorder associated with cancer. The pathophysiological, epidemiological and clinical aspects of hypercalcemia of malignancy are presented in this issue, with a focus on the recently discovered humoral factor responsible for the development of hypercalcemia. With a better understanding of the pathophysiology of this condition and the development of new potent drugs, capable of inhibiting bone resorption, especially bisphosphonates, the clinician will be more successful in correcting hypercalcemia in the great majority of patients. |
| nccn nsclc guidelines 2023: Palliative Care in Oncology Bernd Alt-Epping, Friedemann Nauck, 2015-03-26 Palliative care provides comprehensive support for severely affected patients with any life-limiting or life-threatening diagnosis. To do this effectively, it requires a disease-specific approach as the patients’ needs and clinical context will vary depending on the underlying diagnosis. Experts in the field of palliative care and oncology describe in detail the needs of patients with advanced cancer in comparison to those with non-cancer disease and also identify the requirements of patients with different cancer entities. Basic principles of symptom control are explained, with careful attention to therapy for pain associated with either the cancer or its treatment and to symptom-guided antineoplastic therapy. Complex therapeutic strategies for palliative cancer patients are highlighted that involve both cancer- and symptom-directed options and address a range of therapeutic aims. Issues relating to drug use in palliative cancer care are fully explored, and a separate section is devoted to care in the final phase. A range of organizational and policy issues are also discussed, and the book concludes by considering likely future developments in palliative care for cancer patients. Palliative Care in Oncology will be of particular interest to palliative care physicians who are interested in broadening the scope of their disease-specific knowledge, as well as to oncologists who wish to learn more about modern palliative care concepts relevant to their day-to-day work with cancer patients. |
| nccn nsclc guidelines 2023: Diseases of the Chest, Breast, Heart and Vessels 2019-2022 Gustav K von Schulthess, Rahel A Kubik-Huch, Juerg Hodler, 2020-10-08 This open access book focuses on diagnostic and interventional imaging of the chest, breast, heart, and vessels. It consists of a remarkable collection of contributions authored by internationally respected experts, featuring the most recent diagnostic developments and technological advances with a highly didactical approach. The chapters are disease-oriented and cover all the relevant imaging modalities, including standard radiography, CT, nuclear medicine with PET, ultrasound and magnetic resonance imaging, as well as imaging-guided interventions. As such, it presents a comprehensive review of current knowledge on imaging of the heart and chest, as well as thoracic interventions and a selection of hot topics. The book is intended for radiologists, however, it is also of interest to clinicians in oncology, cardiology, and pulmonology. This work was published by Saint Philip Street Press pursuant to a Creative Commons license permitting commercial use. All rights not granted by the work's license are retained by the author or authors. |
| nccn nsclc guidelines 2023: NCCN Guidelines for Patients® Invasive Breast Cancer National Comprehensive Cancer Network® (NCCN®), 2024-04-18 [OFFICIAL CURRENT VERSION] From the National Comprehensive Cancer Network (NCCN) comes this essential guide to Invasive Breast Cancer. Based on clinical treatment guidelines used by doctors and oncology professionals around the world, these NCCN Guidelines for Patients help patients and caregivers talk with their doctors and make treatment decisions. Topics include: Breast cancer basics, Testing for breast cancer, Breast cancer staging, Treating breast cancer, Surgery first, Preop treatment first, The breast after surgery, Recurrence, Making treatment decisions, Words to know, NCCN Contributors, NCCN Cancer Centers, Index. |
| nccn nsclc guidelines 2023: PET/CT in Head and Neck Cancer Wai Lup Wong, 2018-02-12 This pocket book is an up-to-date guide to the diagnostic imaging of head and neck cancers. The focus is particularly on FDG PET/CT, with coverage of the basic principles, clinical indications, typical and atypical appearances, normal variations and artifacts, advantages, limitations, and pitfalls. Consideration is also given to emerging roles for PET/CT in head and neck cancer, including radiotherapy planning and treatment response monitoring, and to radiotracers beyond FDG. In addition, succinct information is provided on clinical presentation, diagnosis, staging, pathology, management, and other diagnostic imaging techniques. A brief discourse on the practice of guideline adoption is included. The book is published within the Springer series Clinicians’ Guides to Radionuclide Hybrid Imaging (compiled under the auspices of the British Nuclear Medicine Society) and will be an excellent asset for clinicians, nuclear medicine physicians, radiologists, radiographers, technologists, and nurses who work in the field of head and neck cancer. |
| nccn nsclc guidelines 2023: Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease E-Book Joerg Herrmann, 2022-01-11 Today's patients have unique cardiologic needs before, during, and after cancer treatment. Chemotherapies, radiation therapy, and targeted therapies can produce acute side effects or lasting adverse consequences on the heart and circulatory system, making the field of cardio-oncology increasingly important in effective patient care. Cardio-Oncology Practice Manual is a comprehensive, portable guide that provides practical approaches to assessment and management of cardiovascular diseases due to the effects of cardiotoxic agents and treatments. Part of the Braunwald family of renowned cardiology references, it clearly presents clinically relevant aspects of this growing field in one quick, practical reference for a wide range of cardio-oncology providers. - Covers all major cancer therapies, cardiovascular toxicities, and malignancies in a portable, authoritative guide—ideal for cardiologists, cardio-oncologists, general practitioners, internists, medical oncologists, and hematologists. - Offers templated and streamlined content for quick retrieval, with key point summaries for each major section. - Presents cardiac disease entities and specific malignant diseases in a succinct overview format addressing important clinical care aspects. - Features Central Illustrations for each topic that visually summarize the chapter and its specific content including algorithms for management of cardiovascular toxicities and one-view overviews of malignancies. - Includes a comprehensive drug guide that provides quick reference to drugs prescribed for cancers with therapeutic indications, manifestations and mechanisms of cardiotoxicity, their risk factors, and risk reduction strategies. - Brings you up to date with new immune therapies, including immune checkpoint inhibitors and CAR T-cell therapies |
| nccn nsclc guidelines 2023: Molecular Pathology of Lung Cancer Philip T. Cagle, Timothy Craig Allen, Mary Beth Beasley, Lucian R. Chirieac, Sanja Dacic, Alain C. Borczuk, Keith M. Kerr, 2012-06-14 As with other books in the Molecular Pathology Library Series, Molecular Pathology of Lung Cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular Pathology of Lung Cancer provides the latest information and current insights into the molecular basis for lung cancer, including precursor and preinvasive lesions, molecular diagnosis, molecular targeted therapy, molecular prognosis, molecular radiology and related fields for lung cancer generally and for the specific cell types. As many fundamental concepts about lung cancer have undergone revision in only the past few years, this book will likely be the first to comprehensively cover the new molecular pathology of lung cancer. It provides a foundation in this field for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, thoracic radiologists and their trainees, physician assistants, and nursing staff. |
| nccn nsclc guidelines 2023: International Manual of Oncology Practice Ramon Andrade De Mello, Giannis Mountzios, Álvaro A. Tavares, 2019-10-15 Cancer is a very aggressive disease and currently it has been considered a challenge to oncologists and cancer patients worldwide. Nowadays, several therapeutic strategies had improved toward last decades. Surgery is many times still the best curative treatment, mainly in early stage disease. However, Radiotherapy and chemotherapy acquired a main role in this scenario. Target therapies were introduced for medical oncology practice and are demonstrating a hallmark of a new era in cancer treatment. More recently, immunotherapy has been considered the novel cornerstone in cancer treatment. The 2nd edition of the International Manual of Oncology Practice (iMOP) emerged after the great success of the iMOP 1st edition as a reference for medical oncologists and medical residents in the field. In this edition, several chapters were revised and its addresses from the molecular issues of cancer sciences to the clinical practice in medical oncology. In addition, multiple choice questions and clinical cases were included in the main chapters in order to improve the reader learning. The book focuses systemic treatments in many areas of medical oncology, such as breast cancer, gastrointestinal, thoracic, urological oncology, head and neck tumors, bone tumors, sarcomas and palliative care. The topics herein discussed will provide the readers a step forward in the medical oncology practice understanding and give facilities for help in cancer patient treatments. |
| nccn nsclc guidelines 2023: NCCN Guidelines for Patients® Bone Cancer National Comprehensive Cancer Network® (NCCN®), 2024-11-04 [OFFICIAL CURRENT VERSION] From the National Comprehensive Cancer Network (NCCN) comes this essential guide to Bone Cancer. Based on clinical treatment guidelines used by doctors and oncology professionals around the world, these NCCN Guidelines for Patients help patients and caregivers talk with their doctors and make treatment decisions. Topics include: About bone cancer, Testing for bone cancer, Bone cancer staging, Types of treatment, Chondrosarcoma, Chordoma, Ewing sarcoma, Giant cell tumor of bone, Osteosarcoma, Other resources, Words to know, NCCN Contributors, NCCN Cancer Centers, Index. |
| nccn nsclc guidelines 2023: High-Risk Cutaneous Squamous Cell Carcinoma Chrysalyne D. Schmults, 2016-04-29 This book is a cutting-edge resource that provides clinicians with the up-to-date practical knowledge required in order to manage SCC patients optimally. It summarizes newly available information relating to the definition of high-risk SCC, its pathophysiologic underpinnings, and its management. New prognostic information and staging systems are summarized that enable high-risk tumors to be defined more precisely than ever before. Many helpful tips are provided on the practical management of challenging cases, including multiple tumors/field cancerization, high-risk tumors, nodal metastases, and unresectable disease. The authors are all acknowledged experts in the emerging field of high-risk and advanced SCC. |
| nccn nsclc guidelines 2023: Microsatellite Markers Ibrokhim Y. Abdurakhmonov, 2016-11-30 Microsatellite or so-called simple sequence repeat (SSR) markers have been one of the most reliable molecular markers derived from the DNA molecule, which were widely and successfully used for more than 25 years in the genetic studies of environmental, agricultural, and biomedical sciences. The objective of this Microsatellite Markers book is to rehighlight and provide some updates on previous and recent utilization of microsatellite markers for various applications in agriculture and medicine, which void emerging opinion on full death of microsatellites as useful genetic markers. Chapters presented here demonstrate the future benefit of SSRs in many genetic studies as well as disease diagnosis and prognosis. |
| nccn nsclc guidelines 2023: Central Nervous System Metastases Manmeet Ahluwalia, Philippe Metellus, Riccardo Soffietti, 2019-11-05 This book provides a comprehensive overview of brain metastases, from the molecular biology aspects to therapeutic management and perspectives. Due to the increasing incidence of these tumors and the urgent need to effectively control brain metastatic diseases in these patients, new therapeutic strategies have emerged in recent years. The volume discusses all these innovative approaches combined with new surgical techniques (fluorescence, functional mapping, integrated navigation), novel radiation therapy techniques (stereotactic radiosurgery) and new systemic treatment approaches such as targeted- and immunotherapy. These combination strategies represent a new therapeutic model in brain metastatic patients in which each medical practitioner (neurosurgeon, neurologist, medical oncologist, radiation oncologist) plays a pivotal role in defining the optimal treatment in a multidisciplinary approach. Written by recognized experts in the field, this book is a valuable tool for neurosurgeons, neuro-oncologists, neuroradiologists, medical oncologists, radiation oncologists, cognitive therapists, basic scientists and students working in the area of brain tumors. |
| nccn nsclc guidelines 2023: Chemotherapy and Immunotherapy in Urologic Oncology Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi, 2020-09-29 This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book’s chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. |
| nccn nsclc guidelines 2023: Clinical Trials in Oncology, Third Edition Stephanie Green, Jacqueline Benedetti, Angela Smith, John Crowley, 2012-05-09 The third edition of the bestselling Clinical Trials in Oncology provides a concise, nontechnical, and thoroughly up-to-date review of methods and issues related to cancer clinical trials. The authors emphasize the importance of proper study design, analysis, and data management and identify the pitfalls inherent in these processes. In addition, the book has been restructured to have separate chapters and expanded discussions on general clinical trials issues, and issues specific to Phases I, II, and III. New sections cover innovations in Phase I designs, randomized Phase II designs, and overcoming the challenges of array data. Although this book focuses on cancer trials, the same issues and concepts are important in any clinical setting. As always, the authors use clear, lucid prose and a multitude of real-world examples to convey the principles of successful trials without the need for a strong statistics or mathematics background. Armed with Clinical Trials in Oncology, Third Edition, clinicians and statisticians can avoid the many hazards that can jeopardize the success of a trial. |
| nccn nsclc guidelines 2023: Hyperthermia in Cancer Therapy F. Kristian Storm, 1983 |
| nccn nsclc guidelines 2023: Quick Reference for Oncology Clinicians Jimmie C. Holland, Donna Bea Greenberg, Mary K. Hughes, 2006-01-01 |
| nccn nsclc guidelines 2023: The Health Consequences of Involuntary Exposure to Tobacco Smoke , 2006 This Surgeon General's report returns to the topic of the health effects of involuntary exposure to tobacco smoke. The last comprehensive review of this evidence by the Department of Health and Human Services (DHHS) was in the 1986 Surgeon General's report, The Health Consequences of Involuntary Smoking, published 20 years ago this year. This new report updates the evidence of the harmful effects of involuntary exposure to tobacco smoke. This large body of research findings is captured in an accompanying dynamic database that profiles key epidemiologic findings, and allows the evidence on health effects of exposure to tobacco smoke to be synthesized and updated (following the format of the 2004 report, The Health Consequences of Smoking). The database enables users to explore the data and studies supporting the conclusions in the report. The database is available on the Web site of the Centers for Disease Control and Prevention (CDC) at http://www.cdc.gov/tobacco. |
| nccn nsclc guidelines 2023: Thoracic Medicine Peter Emerson, 1981 |
| nccn nsclc guidelines 2023: Who Classification of Tumours of the Lung, Pleura, Thymus and Heart International Agency for Research on Cancer, 2015-03-16 WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart is the seventh volume in the Fourth Edition of the WHO series on histological and genetic typing of human tumors. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome. |
| nccn nsclc guidelines 2023: The MD Anderson Manual of Medical Oncology Hagop M. Kantarjian, Robert A. Wolff, Charles A. Koller, 2006-03-22 A concise, up-to-date clinician's guide to cancer management -- from the leaders in the field A Doody's Core Title! The MD Anderson Cancer Center is ranked as the world's leading institution in cancer medicine. With publication of the MD Anderson Manual of Medical Oncology, the editorial board of this prestigious institution makes available for the first time a resource that meets the needs of clinicians for an authoritative, accessible guide to the medical management of patients with cancer and its complications. Straight-to-the-point, state-of-the-art strategies for cancer management Gives physicians a current, coherent approach to each disease and situation -- imbued with the clinical expertise and teaching authority of world class oncology researchers/practitioners Consistently formatted for a unified patient management strategy Packed with time-saving features, including “The M.D. Anderson Work-Up Box” and “The M.D. Anderson Preferred Treatment Box” Examines special issues in breast cancer management…current treatment strategies for infection in the neutropenic patient and management of fungal and viral infections in cancer patients… basic concepts and controversies related to allogeneic marrow transplantation…more Provides guidelines for oncologic emergencies and palliative care Outlines procedures for symptom control in long-term survival… long-term follow-up in pediatric and adult patients…and rehabilitation |
| nccn nsclc guidelines 2023: Accelerated Partial Breast Irradiation David E. Wazer, Douglas W. Arthur, Frank Vicini, 2009-09-02 This text is a concise handbook designed to assist the clinician in the implementation of Accelerated Partial Breast Irradiation (APBI). It includes a review of the principles that underlie APBI, a practical and detailed description of each technique for APBI, a review of current clinical results of APBI, and a review of the incidence and management of treatment related complications. The book encompasses a number of different techniques and approaches that include brachytherapy, intraoperative, and external beam techniques. There is currently no single source that describes these techniques and their clinical implementation. |
| nccn nsclc guidelines 2023: MEDINFO 2023 — The Future Is Accessible J. Bichel-Findlay, P. Otero, P. Scott, 2024-04-02 Science-fiction author William Gibson is famously quoted as saying, “The future is already here – it's just not very evenly distributed.” During the Covid pandemic, telehealth and remote monitoring were elevated from interesting innovations to essential tools in many healthcare systems, but not all countries had the infrastructure necessary to pivot quickly, amply demonstrating the negative consequences of the digital divide. This book presents the proceedings of MedInfo 2023, the 19th World Congress on Medical and Health Informatics, held from 8 – 12 July 2023 in Sydney, Australia. This series of biennial conferences provides a platform for the discussion of applied approaches to data, information, knowledge, and wisdom in health and wellness. The theme and title of MedInfo 2023 was The Future is Accessible, but the digital divide is a major concern for health and care-informatics professionals, whether because of global economic disparities, digital literacy gaps, or limited access to reliable information about health. A total of 935 submissions were received for the conference, of which 228 full papers, 43 student papers and 117 posters were accepted following a thorough peer-review process involving 279 reviewers. Topics covered include: information and knowledge management; quality, safety and outcomes; health data science; human, organizational and social aspects; and global health informatics. Significant advances in artificial intelligence, machine learning, augmented reality, virtual reality, and genomics hold great hope for future healthcare planning, delivery, management, education, evaluation, and research, and this book will be of interest to all those working to not only exploit the benefits of these technologies, but also to identify ways to overcome their associated challenges. |
| nccn nsclc guidelines 2023: Advances in the use of EGFR TKIs in the Treatment of NSCLC Paola Ulivi, Yusuke Okuma , Santiago Viteri, 2024-11-18 Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all cases. Over the last decade, there have been significant advances in the treatment of NSCLC, particularly with the use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). EGFR is a key driver of NSCLC, and EGFR TKIs have shown remarkable clinical activity in patients with EGFR-mutant NSCLC. Despite these advances, however, there are still many unanswered questions regarding the optimal use of EGFR TKIs in the treatment of NSCLC. To improve patient outcomes, further research into the use of EGFR TKIs in lung cancer therapy is vital. Our goal is to provide an overview of the latest advances in the use of EGFR TKIs in the treatment of NSCLC. |
| nccn nsclc guidelines 2023: Advances in Clinical Radiology, 2024 Frank H. Miller, 2024-08-05 Advances in Clinical Radiology reviews the year's most important findings and updates within the field in order to provide radiologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Frank H. Miller, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in radiology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care. - Contains 25 articles on such topics as 2022 WHO classification of renal cell carcinomas: a primer for radiologists; AI applications in pancreatic cancer imaging; advancing radioembolization through personalized dosimetry; value of direct MR arthrography; update on lung cancer screening; 3D printing: a revolutionary technology to clinical practice; and more. - Provides in-depth, clinical reviews in clinical radiology, providing actionable insights for clinical practice. - Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. |
| nccn nsclc guidelines 2023: Diagnostic Pathology: Molecular Oncology E-Book Mohammad A. Vasef, Aaron Auerbach, 2023-12-04 This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Providing a clear understanding of molecular pathology as it relates to the transformation and pathogenesis of cancer in an era of personalized medicine, it incorporates the most recent scientific and technical knowledge in the field to provide a comprehensive overview of all key issues relevant to today's practice. Richly illustrated and easy to use, the third edition of Diagnostic Pathology: Molecular Oncology is a visually stunning, one-stop resource for every practicing pathologist, hematopathologist, molecular pathologist, oncologist, or pathologist in training as an ideal day-to-day reference or as a reliable learning resource. - Provides up-to-date, comprehensive coverage of relevant molecular tests and their clinical applications, along with organ-based chapters on the molecular genetic data relevant to individual disease entities - Contains new chapters and substantial revisions to existing content that include updates from the 2022 International Consensus Classification and the WHO Classification of Haematolymphoid Tumours, fifth edition - Provides expert guidance on selecting the right test(s) at the right time, as well as comparisons of molecular testing methods (e.g., FISH vs. cytogenetics) - Includes current information for new actionable mutations and targeted therapies - Covers ultrasensitive molecular techniques for minimal residual disease detection and disease monitoring - Discusses circulating cell-free DNA analysis for detection of resistance-associated mutations and disease monitoring, and provides usage details - Features an image-rich layout with more than 2,400 print and online-only images, including high-resolution H&E stains, immunostains, FISH images, gross pathology and clinical photographs, detailed full-color medical illustrations, and informative diagrams, charts, and schematics - Employs consistently templated chapters, bulleted content, key facts, a variety of tables, annotated images, pertinent references, and an extensive index for quick, expert reference at the point of care - Any additional digital ancillary content may publish up to 6 weeks following the publication date |
| nccn nsclc guidelines 2023: Lung Cancer E-Book Erin Alexis Gillaspie, Leora Horn, Amanda S. Cass, 2023-08-24 Care of the lung cancer patient—screening, diagnosis, and treatment—has undergone recent dramatic changes due to technologic and research-driven advances. Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management covers every aspect of this fast-changing field, including new screening guidelines, new practice standards, and new treatment advances that have led to higher survival rates. This practical, clinically oriented resource provides thorough, evidence-based coverage from experts in the field, including the increasingly important precision medicine approach in lung cancer planning and management. - Discusses key topics such as small cell and non-small cell lung cancers; immunotherapy, molecular cohorts including ROS1, BRAF, HER2, Met, and NTRK; oligometastatic disease; and more. - Covers individualized treatment plans for chemotherapy, radiotherapy, targeted biomarker-derived therapies, and new and emerging immunotherapies. - Provides excellent visual guidance throughout, including algorithms, pathology specimens, anatomic drawings, and PET/CT and CT imaging for diagnosis and treatment planning. - Features Top 5 Clinical Pearls at the beginning of each chapter. - Shares the experience and knowledge of medical oncologists, radiation oncologists, surgical oncologists, and thoracic radiologists for a real-world tumor board perspective. |
| nccn nsclc guidelines 2023: Epidemiology, screening and diagnosis of lung cancer Yutong He, Xue Qin Yu, Chen Wanqing, Jackilen Shannon, Yingsong Lin, 2023-05-08 |
| nccn nsclc guidelines 2023: A Practical Guide to MR-Linac Indra J. Das, Filippo Alongi, Poonam Yadav, Bharat B. Mittal, 2024-03-20 This book offers a detailed guide to MR-Linac, a unique and fast growing radiation treatment modality. MR-linac is new technology that is a fusion of an MRI and a linear accelerator on the same gantry. It can change both target volume delineation and tumor visualization in real time using MR-cine images and treatment. Tumor location changes moment to moment as radiation is delivered, but this cannot be visualized in current radiation therapy practices. This new and rapidly growing technology can provide adaptive therapy that was not possible before. This book presents current knowledge on MR-linac technology, clinical practices, and ultimately patient outcome where dose escalation is not possible due to limiting normal tissue structures in the vicinity of tumor. There are two commercial MR-linac machines under consideration and both will be covered in detail. The book is divided into four sections. The first gives a general introduction to MR-Linac, covering the role of MRI inradiation oncology, the clinical necessity of this technology, and patient selection. The next section details the physics and technology of MR-Linac, covering image sequence, motion management, and treatment planning. Section three offers the clinical applications of MR-Linac and is divided by body area, including lung, prostate, and breast. Finally, the fourth section looks to the future and what this technology can mean for radiation oncology. This is an ideal guide for radiation oncologists, medical physicists, and relevant trainees. |
| nccn nsclc guidelines 2023: Difficult Decisions in Thoracic Surgery Mark K. Ferguson, 2025-02-10 As the complexity of decision-making in medicine, and surgery in particular, is growing exponentially, this book provides a practical guide to decision-making in thoracic surgery. It offers guidance on how to select among the varied and complex approaches that new technology provides. Concise and easy to follow chapters are devoted to one or two specific questions or decisions in thoracic surgery, aiding the reader to develop their decision-making skills. Difficult Decisions in Thoracic Surgery offers clearly formatted and evidence-based chapters to help the reader navigate the complexities of thoracic surgery. All new chapters bring insight into the challenges faced operating on the lung, esophagus, diaphragm, airway, pleaura, mediastinum, and chest wall. The book is relevant to practicing surgeons, surgeons in training, as well as medical professionals working with thoracic diseases. |
| nccn nsclc guidelines 2023: Textbook for the Adult-Gerontology Acute Care Nurse Practitioner Valerie J. Fuller, PhD, DNP, AGACNP-BC, FNP-BC, FNAP, FAANP, Paula S. McCauley, DNP, ACNP-BC, CMC, CSC, FAANP, 2023-02-13 Nearly 100 expert authors who discuss the evidence-based gold standards for diagnostics and tests for optimal detection of multisystem disorders, patient management, and transitions of care. In these chapters, learners will gain greater understanding of the etiology and pathophysiology of acute and critical illnesses, and the latest in advanced pharmacologic and nonpharmacologic therapies... We congratulate the Editors and chapter authors for their efforts in developing a clearly outlined and accurate text for AGACNP use—truly the first of its kind. —April N. Kapu, DNP, APRN, ACNP-BC, FAANP, FCCM, FAAN Associate Dean for Clinical and Community Partnerships Vanderbilt University School of Nursing Professor of Nursing, Vanderbilt University School of Nursing 2021-2023 President, American Association of Nurse Practitioners —Ruth Kleinpell, PhD, APRN, ACNP-BC, FAANP, FAAN, MCCM Associate Dean for Clinical Scholarship, Vanderbilt University School of Nursing Professor of Nursing, Vanderbilt University School of Nursing 2017 President, Society of Critical Care Medicine Encompassing all of the knowledge required to fulfill AACN and NONPF competencies and scope of practice, this comprehensive, evidence-based text is the first written specifically for Adult Gerontology Acute Care NP students and practitioners. With contributions from over 100 respected practitioners in the field, it encompasses the most current information on the evaluation, diagnosis, and management of common conditions, and integrates advanced nursing practice competencies including leadership skills, understanding of complex health care systems, and interprofessional team practice. The text is organized by body system for ease of reference. Each chapter includes a review of the current standard of care for a particular topic, including assessment, differential diagnostic modalities, interprofessional collaboration, evidence-based treatment, and goals for transitions of care. Also covered are specific challenges and professional considerations in acute care. Clinical pearls and key takeaway boxes are woven throughout to underscore essential information. Special topics on palliative care, pain, and pain management are also covered. Instructor resources include PowerPoints and a test bank. Key Features: A comprehensive acute care textbook written by NPs for NPs Organized by body system for ease of reference Integrates advanced nursing practice competencies Promotes leadership skills, helps students to understand complex health care systems, and embodies core principles of interprofessional team practice Includes clinical pearls, key takeaway boxes, evidence-based practice resources Delivers robust teaching/learning package |
| nccn nsclc guidelines 2023: Sabiston and Spencer Surgery of the Chest, E-Book Frank W. Sellke, Pedro J. del Nido, Scott J. Swanson, 2023-09-27 **Selected for Doody's Core Titles® 2024 in Thoracic Surgery**The only text to cover the full range of adult cardiac, thoracic, and pediatric chest surgery, Sabiston and Spencer Surgery of the Chest, 10th edition provides unparalleled guidance in a single, two-volume resource. This gold standard reference, edited by Drs. Frank Sellke, Pedro del Nido, and Scott Swanson, covers today's most important knowledge and techniques in cardiac and thoracic surgery—the information you need for specialty board review and for day-to-day surgical practice. Meticulously organized so that you can quickly find expert information on open and endoscopic surgical techniques, this 10th Edition is an essential resource not only for all cardiothoracic surgeons, but also for physicians, residents, and students concerned with diseases of the chest. - Features short, focused chapters divided into three major sections: Adult Cardiac Surgery, Pediatric Cardiac Surgery, and Thoracic Surgery - Presents the knowledge and expertise of global experts who provide a comprehensive view of the entire specialty - Provides full-color coverage throughout, helping you visualize challenging surgical techniques and procedures and navigate the text efficiently - Includes new chapters on dissection complications and percutaneous treatment of mitral and tricuspid valve disease - Offers extensively revised or rewritten chapters on surgical revascularization, acute dissection, vascular physiology, the latest innovations in minimally invasive cardiothoracic surgery and percutaneous devices, the molecular biology of thoracic malignancy, robotics in chest surgery, congenital valve reconstructions, novel hybrid procedures in pediatric cardiac surgery, and 3D visualization of cardiac anatomy for surgical procedure planning - Keeps you up to date with the latest developments in cardiothoracic imaging and diagnosis - Provides access to more than 30 surgical videos online, and features new figures, tables, and illustrations throughout |
| nccn nsclc guidelines 2023: FUTURISTIC RESEARCH AND INNOVATION IN NURSING, HUMANITIES AND MANAGEMENT Dr. Sammi Kumari, 2024-04-27 We realised that this book will create a lot of excitement, and challenge, joy, and happiness among all of us. Challenging consensus is never easy. This is because the system will try to maintain the status quo by any means necessary in any situation, of any type. After years of experience in the field of Management, Nursing, and Research we feel the need to share our knowledge, analysis, and conclusions. We hope it ignites a discussion that could lead to major cultural changes and shopping cart overhauls. The beneficiaries will be all of us – ourselves, our students, our loved ones, and society at large – living healthier and longer. Management research is challenging, exciting, engaging, and rewarding. The main idea of editing/writing this book is to help students from different fields and prepare and motivate them for more research. The purpose of writing this book was to make research more interesting for all students in different fields. It differs in approach and content from all other interdisciplinary textbooks. It will contain the work of all aspiring students of undergraduate, Postgraduate, and doctoral Research (M.Phil. and Ph.D.). It will help the research scholars to publish their original research work in an ISBN book. Futuristic Research and Innovation in Nursing, Humanities, and Management provides information to all students about research findings and provides new information to develop new foundations for the research profession. |
| nccn nsclc guidelines 2023: Reviews in thoracic oncology Nikolaos I Kanellakis, Youxin Ji, 2023-06-07 |
| nccn nsclc guidelines 2023: Extracellular vesicles: From characterization to treatment Xinlei Li, Jeffrey David Galley, Ming Dong, 2023-03-30 |
| nccn nsclc guidelines 2023: Case reports in molecular and cellular oncology: 2022 Sunil Reddy, Omer Faruk Bayrak, Ning Ji, Shuhua Zheng, Linli Zhang, 2023-06-08 |
| nccn nsclc guidelines 2023: KRAS in Stage IV Non-Small Cell Lung Cancer Georgia Hardavella, Torsten Gerriet Blum, Wouter H. Van Geffen, 2025-03-21 The oncogenic impacts of the KRAS gene were first reported in the 1980s, making KRAS one of the first identified oncogenes. A KRAS mutation occurs in nearly 30% of human cancers. Also in NSCLC KRAS mutations are often observed. In western populations, KRAS is the most common oncogenic driver mutation in NSCLC, occurring in 30% of patients. In patients with non-small cell lung cancer (NSCLC) that harbor a KRAS mutation, the KRAS G12C sub mutation is seen in 40-45%. Now that G12C inhibitors are available as a second line of therapy in metastatic NSCLC patients with a KRAS G12C mutation, we aim within this Research Topic to learn more about KRAS and its sub mutations and co-mutations in NSCLC. |
Latest Medical News, Clinical Trials, Guidelines - Today on Medscape
4 days ago · Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
Breast Cancer Guidelines Compared: ESMO vs NCCN - Medscape
Apr 9, 2015 · The NCCN says that intervals for follow-up mammograms should be every 12 months, whereas the ESMO says every 1 to 2 years. Overall, laboratory tests are "not …
New NCCN Guidelines for Mammography: All Women Over 40
Jul 29, 2022 · "These NCCN patient guidelines are an easy way for people to access up-to-date expert recommendations in plain language." Sharon Worcester, MA, is an award-winning …
NCCN Expands Cancer Genetic Risk Assessment Guidelines
Nov 20, 2024 · The National Comprehensive Cancer Network (NCCN) has expanded two cancer genetic risk assessment guidelines to meet the growing understanding of hereditary cancer …
Multigene Testing in Pancreatic Cancer: NCCN Impact - Medscape
May 12, 2025 · Post NCCN recommendations for the testing, that number increased minimally to 39%, of whom 75% of that population had the testing. WithNCCN recommendations, still only …
Breast Cancer Guideline Updated at 2011 NCCN - Medscape
Mar 11, 2011 · The NCCN guidance reads: "Randomized clinical trials in metastatic breast cancer document that the addition of bevacizumab to some first- or second-line chemotherapy agents …
NCCN Guidelines Embrace PSMA-PET Imaging for Prostate Cancer …
Sep 28, 2021 · The footnote in the new NCCN guidelines states that "because of the increased sensitivity and specificity of PSMA-PET tracers for detecting micrometastatic disease …
New ASCO Guidelines for Advanced Ovarian Cancer - Medscape
Feb 24, 2025 · Based on the NCCN guidelines, treatment selection for ovarian cancer is primarily determined by the histologic subtype, stage of disease, and whether the patient is a candidate …
The Latest Guidelines for Pain Management - Medscape
Dec 6, 2010 · Editor's note. This is the second in a 2-part article describing the changes to the National Comprehensive Cancer Network's (NCCN) updated 2010 guidelines on the …
Shock, Disbelief as NCCN Changes Prostate Cancer Guidance
Nov 12, 2021 · The NCCN's move to alter its low-risk prostate cancer guidance is especially striking because, 11 years ago, the NCCN broke new ground in recommending active …
Latest Medical News, Clinical Trials, Guidelines - Today on Medscape
4 days ago · Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
Breast Cancer Guidelines Compared: ESMO vs NCCN - Medscape
Apr 9, 2015 · The NCCN says that intervals for follow-up mammograms should be every 12 months, whereas the ESMO says every 1 to 2 years. Overall, laboratory tests are "not recommended" by …
New NCCN Guidelines for Mammography: All Women Over 40
Jul 29, 2022 · "These NCCN patient guidelines are an easy way for people to access up-to-date expert recommendations in plain language." Sharon Worcester, MA, is an award-winning medical …
NCCN Expands Cancer Genetic Risk Assessment Guidelines
Nov 20, 2024 · The National Comprehensive Cancer Network (NCCN) has expanded two cancer genetic risk assessment guidelines to meet the growing understanding of hereditary cancer risk …
Multigene Testing in Pancreatic Cancer: NCCN Impact - Medscape
May 12, 2025 · Post NCCN recommendations for the testing, that number increased minimally to 39%, of whom 75% of that population had the testing. WithNCCN recommendations, still only …
Breast Cancer Guideline Updated at 2011 NCCN - Medscape
Mar 11, 2011 · The NCCN guidance reads: "Randomized clinical trials in metastatic breast cancer document that the addition of bevacizumab to some first- or second-line chemotherapy agents …
NCCN Guidelines Embrace PSMA-PET Imaging for Prostate Cancer …
Sep 28, 2021 · The footnote in the new NCCN guidelines states that "because of the increased sensitivity and specificity of PSMA-PET tracers for detecting micrometastatic disease compared …
New ASCO Guidelines for Advanced Ovarian Cancer - Medscape
Feb 24, 2025 · Based on the NCCN guidelines, treatment selection for ovarian cancer is primarily determined by the histologic subtype, stage of disease, and whether the patient is a candidate …
The Latest Guidelines for Pain Management - Medscape
Dec 6, 2010 · Editor's note. This is the second in a 2-part article describing the changes to the National Comprehensive Cancer Network's (NCCN) updated 2010 guidelines on the management …
Shock, Disbelief as NCCN Changes Prostate Cancer Guidance
Nov 12, 2021 · The NCCN's move to alter its low-risk prostate cancer guidance is especially striking because, 11 years ago, the NCCN broke new ground in recommending active surveillance as the …
